vs
Side-by-side financial comparison of Porch Group, Inc. (PRCH) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $121.1M, roughly 1.3× Porch Group, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -3.9%, a 75.1% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 100.0%).
Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
PRCH vs STOK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $121.1M | $158.6M |
| Net Profit | $-4.7M | $112.9M |
| Gross Margin | 52.7% | — |
| Operating Margin | 34.7% | 70.2% |
| Net Margin | -3.9% | 71.2% |
| Revenue YoY | 100.0% | 3661.1% |
| Net Profit YoY | 2.0% | 528.0% |
| EPS (diluted) | $-0.04 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $121.1M | — | ||
| Q4 25 | $112.3M | — | ||
| Q3 25 | $115.1M | — | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | $84.5M | $158.6M | ||
| Q4 24 | $75.3M | $22.6M | ||
| Q3 24 | $77.7M | — | ||
| Q2 24 | $75.9M | — |
| Q1 26 | $-4.7M | — | ||
| Q4 25 | $-3.5M | — | ||
| Q3 25 | $-10.9M | — | ||
| Q2 25 | $2.6M | — | ||
| Q1 25 | $8.4M | $112.9M | ||
| Q4 24 | $30.5M | $-10.5M | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $-64.3M | — |
| Q1 26 | 52.7% | — | ||
| Q4 25 | 99.5% | — | ||
| Q3 25 | 75.6% | — | ||
| Q2 25 | 70.9% | — | ||
| Q1 25 | 77.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 79.4% | — | ||
| Q2 24 | 22.1% | — |
| Q1 26 | 34.7% | — | ||
| Q4 25 | 14.7% | — | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | -1.5% | 70.2% | ||
| Q4 24 | 33.3% | -60.4% | ||
| Q3 24 | -3.2% | — | ||
| Q2 24 | -69.2% | — |
| Q1 26 | -3.9% | — | ||
| Q4 25 | -3.1% | — | ||
| Q3 25 | -9.4% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 9.9% | 71.2% | ||
| Q4 24 | 40.5% | -46.4% | ||
| Q3 24 | 18.5% | — | ||
| Q2 24 | -84.8% | — |
| Q1 26 | $-0.04 | — | ||
| Q4 25 | $0.00 | — | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $0.07 | $1.90 | ||
| Q4 24 | $0.34 | $-0.15 | ||
| Q3 24 | $0.12 | — | ||
| Q2 24 | $-0.65 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $68.4M | $274.8M |
| Total DebtLower is stronger | $391.3M | — |
| Stockholders' EquityBook value | $26.3M | $350.1M |
| Total Assets | $806.6M | $406.9M |
| Debt / EquityLower = less leverage | 14.87× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $68.4M | — | ||
| Q4 25 | $57.3M | — | ||
| Q3 25 | $85.0M | — | ||
| Q2 25 | $79.8M | — | ||
| Q1 25 | $70.4M | $274.8M | ||
| Q4 24 | $191.7M | $128.0M | ||
| Q3 24 | $238.6M | — | ||
| Q2 24 | $308.4M | — |
| Q1 26 | $391.3M | — | ||
| Q4 25 | $392.8M | — | ||
| Q3 25 | $387.1M | — | ||
| Q2 25 | $394.1M | — | ||
| Q1 25 | $409.2M | — | ||
| Q4 24 | $403.9M | — | ||
| Q3 24 | $399.0M | — | ||
| Q2 24 | $436.8M | — |
| Q1 26 | $26.3M | — | ||
| Q4 25 | $-24.6M | — | ||
| Q3 25 | $-27.9M | — | ||
| Q2 25 | $-29.3M | — | ||
| Q1 25 | $-52.4M | $350.1M | ||
| Q4 24 | $-43.2M | $229.0M | ||
| Q3 24 | $-77.0M | — | ||
| Q2 24 | $-101.9M | — |
| Q1 26 | $806.6M | — | ||
| Q4 25 | $797.4M | — | ||
| Q3 25 | $787.7M | — | ||
| Q2 25 | $770.7M | — | ||
| Q1 25 | $802.3M | $406.9M | ||
| Q4 24 | $814.0M | $271.6M | ||
| Q3 24 | $867.3M | — | ||
| Q2 24 | $876.1M | — |
| Q1 26 | 14.87× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.2M | — | ||
| Q3 25 | $40.8M | — | ||
| Q2 25 | $35.6M | — | ||
| Q1 25 | $-11.2M | $131.8M | ||
| Q4 24 | $-26.6M | $-23.2M | ||
| Q3 24 | $12.4M | — | ||
| Q2 24 | $-26.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.1M | — | ||
| Q3 25 | $40.7M | — | ||
| Q2 25 | $35.4M | — | ||
| Q1 25 | $-11.2M | $131.7M | ||
| Q4 24 | $-26.8M | $-23.2M | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $-26.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | — | ||
| Q3 25 | 35.4% | — | ||
| Q2 25 | 33.0% | — | ||
| Q1 25 | -13.3% | 83.0% | ||
| Q4 24 | -35.6% | -102.7% | ||
| Q3 24 | 15.7% | — | ||
| Q2 24 | -34.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.3% | 0.2% | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 13.79× | — | ||
| Q1 25 | -1.33× | 1.17× | ||
| Q4 24 | -0.87× | — | ||
| Q3 24 | 0.86× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
